Research and Development

Showing 15 posts of 9612 posts found.

J&J image

Patients sue J&J for $800m for ‘hiding antibiotic side effects’

January 22, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Janssen, Johnson and Johnson, Levaquin, Margaret Hamburg, lawsuit, levofloxacin

Six users of Johnson & Johnson’s antibiotic Levaquin are to sue the company for up to $870 million, claiming the …
j

Merck appoints Jessie English to lead discovery team

January 22, 2016 Research and Development Jessie English, Merck

Merck has appointed Jessie English as the new vice president of discovery, translational innovation platform immuno-oncology, effective February 16, 2016. …
China pharmacy

Five charged in US for scheme to steal GSK secrets

January 21, 2016 Research and Development China, GSK, employee theft, trade secrets

Five people have been charged in the US for a scheme to steal secrets from British drugmaker GlaxoSmithKline and then …
WEF

Pharma leads global call for action on antimicrobial resistance

January 21, 2016 Manufacturing and Production, Research and Development Davos, Lord Jim O'Neill, Review on antimicrobial resistance, World Economic Forum, antibiotic resistance, antimicrobial resistance

More than 70 leading international pharmaceutical and biotechnology companies, as well as industry associations, have come together to call for …
GAVI logo

MSD and GAVI agree Ebola vaccine deal

January 20, 2016 Manufacturing and Production, Research and Development Ebola, GAVI, MSD, WHO

MSD and the global vaccine alliance Gavi have agreed a deal to provide 300,000 dosesof  an Ebola virus vaccine, to …
eli_lilly_logo

Lilly awaits FDA review of new arthritis treatment

January 20, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Eli Lilly, FDA, Incyte, NDA, baricitinib, lilly, new drug application, rheumatoid arthritis

Eli Lilly has submitted a new drug application (NDA) to the FDA for baricitinib as a treatment for moderate-to-severe rheumatoid …
Arzerra

Arzerra approved by US FDA for leukaemia

January 20, 2016 Research and Development, Sales and Marketing Afrezza, CLL, FDA, Genmab, Novartis, chronic lymphocytic leukaemia, ofatumumab, sBLA, supplementary biologics license application

The FDA has signed-off a supplemental Biologics License Application (sBLA), meaning Arzerra is approved for extended treatment of patients who …

J&J to cut up to 3,000 jobs in key business unit

January 20, 2016 Manufacturing and Production, Research and Development Jobs, Johnson and Johnson, pharmajobs, redundancies

Johnson & Johnson has announced a restructuring of its medical devices business unit that could result in up to 3,000 …
Marisol Touraine

French Health Minister criticises CRO’s slow response to clinical trial accident

January 19, 2016 Manufacturing and Production, Research and Development Bial, Biotrial, Marisol Tourain, clinical trial

Days after the clinical trial accident that left one participant dead and five hospitalised with neurological problems, French Health Minister …
merck_logo_small

Merck appoints new executive board members

January 19, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck

Merck has appointed two new members to its executive board: Udit Batra (45), head of the Life Science business sector, …
stephen_stamp

Ergomed announces board changes

January 19, 2016 Manufacturing and Production, Research and Development, Sales and Marketing ergomed, primevigilance

Ergomed, a specialist provider of drug development services to the pharmaceutical industry, has announced that Neil Clark, current chief financial …
cosentyx

Two new US approvals for Novartis’ Cosentyx

January 18, 2016 Research and Development, Sales and Marketing Cosentyx, Novartis

Novartis has won FDA approval for Cosentyx (secukinumab) for the treatment of two new indications – adults with active ankylosing …
eye_iris

Blow for Eleven Biotherapeutics as eye drug fails in late-stage trial

January 18, 2016 Research and Development, Sales and Marketing Eleven Biotherapeutics, allergic conjunctivitis, isunakinra

A study by Eleven Biotherapeutics to prove the clinical value of its eye drug isunakinra has flopped, after the drug …
biotrial_facility_rennes

Man left brain dead after clinical trial dies in hospital

January 18, 2016 Research and Development, Sales and Marketing Bial, Biotrial, clinical trial

A man left brain dead after a clinical trial in France has died in hospital and five remain in a …
french_health_ministry

Clinical trial accident leaves six critical, one ‘brain dead’

January 15, 2016 Medical Communications, Research and Development France, clinical trial

Six patients have been left in a critical condition following a serious accident in a clinical trial at a French …
The Gateway to Local Adoption Series

Latest content